|
1
|
Cheung DA, Tamariz L, Nemeth Z, Langshaw AH. Usefulness of Procalcitonin in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. CROHN'S & COLITIS 360 2019. [DOI: 10.1093/crocol/otz032] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
Abstract
Background
Mixed results are reported for procalcitonin (PCT) as biomarkers of infection and disease activity in inflammatory bowel disease (IBD).
Method
We systematically evaluated and performed a meta-analysis on the usefulness of PCT in assessing infection and disease activity in IBD.
Results
The pooled standardized mean difference of PCT for those with infection compared with those without was 1.59 (95% CI, 0.72–2.46, P < 0.01) and those with active disease compared with those without was 1.22 (95% CI, 0.66–1.78, P < 0.01), respectively.
Conclusion
PCT may potentially be useful in differentiating an infectious process from IBD and active from inactive IBD.
Collapse
Affiliation(s)
- Donna Ann Cheung
- Division of Pediatric Gastroenterology, Hepatology, Pancreatology and Nutrition, Stead Family Department of Pediatrics, University of Iowa, Iowa City, IA
| | - Leonardo Tamariz
- Division of Population Health and Computational Medicine, Department of Medicine, University of Miami, Miami, FL
| | - Zsuzsanna Nemeth
- Department of Health Informatics, Leonard M. Miller School of Medicine, University of Miami, Miami, FL
| | - Amber Hamid Langshaw
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Miami, Miami, FL
| |
Collapse
|